Storia in 2 fonti

Fredun Pharmaceuticals Q4 profit rises 56%, announces bonus shares

Fredun Pharmaceuticals reported a 56% rise in Q4 profit, declared a dividend and announced a 2:1 bonus share issue after strong FY26 growth.

Raccontata da

thehindubusinessline.com

economictimes.indiatimes.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

thehindubusinessline.comStai leggendo5 g fa

Fredun Pharmaceuticals Q4 profit rises 56%, announces bonus shares

Fredun Pharmaceuticals posted Q4 net profit of ₹11 crore (+56% YoY), with FY26 full-year revenue up 40% to ₹639 crore and EBITDA up 72% to ₹95 crore, alongside a 2:1 bonus share issuance. Margin expansion outpacing revenue growth signals a mix shift toward higher-value segments (nutraceuticals, cosmeceuticals, hormone therapy) — a model worth tracking for pharma stack and contract manufacturing decisions in the Indian generics space.

originale

economictimes.indiatimes.com4 g fa

Fredun Pharmaceuticals board approves 2:1 bonus issue

Fredun Pharmaceuticals board has recommended a 2:1 bonus issue, granting two new equity shares for every one held. This decision aims to reward shareholders, reflecting management's confidence in the companys sustained…

Leggi questa versione → originale

Timeline cronologica

lunedì 25 maggio 2026·thehindubusinessline.com
Fredun Pharmaceuticals Q4 profit rises 56%, announces bonus shares
Fredun Pharmaceuticals reported a 56% rise in Q4 profit, declared a dividend and announced a 2:1 bonus share issue after strong FY26 growth.
martedì 26 maggio 2026·economictimes.indiatimes.com
Fredun Pharmaceuticals board approves 2:1 bonus issue
Fredun Pharmaceuticals board has recommended a 2:1 bonus issue, granting two new equity shares for every one held. This decision aims to reward shareholders, reflecting…